New analysis from Alzheimer’s Research UK has revealed that dementia remained the UK’s leading cause of death in 2024, ...

Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...

New research suggests weight-loss drug semaglutide fails to slow down the decline in memory and thinking in people with early ...

The festive season is a time to come together and spend time with the people you love. Are you looking for presents that ...

Hollywood actor Chris Hemsworth has released a documentary which follows his father Craig, who is living with Alzheimer’s ...

Race Against Dementia Fellowships are designed to power outstanding early career scientists in their pursuit of innovative solutions to the big questions in dementia research. Race Against Dementia ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Age is the biggest risk factor for the development of DLB, this means that the older we are the more likely it becomes. We know that conditions like high blood pressure, high cholesterol and diabetes ...

Health inequalities in the UK are damaging brain health, reducing life expectancy, and incurring significant costs – to individuals and society. These disparities are avoidable, unjust, and on the ...

People with type 2 diabetes in mid-life have an increased risk of developing dementia, in particular vascular dementia, compared to people without diabetes. Diabetes is the term used to describe a ...

It was at Christmas that David’s sons first saw the signs he had Alzheimer's disease. David was fortunate to get a fast diagnosis and joined a clinical trial for donanemab, which slowed his symptoms ...